Tenet Healthcare (NYSE:THC) Upgraded by Wall Street Zen to Strong-Buy Rating

Tenet Healthcare (NYSE:THC) was upgraded by research analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report released on Sunday.

A number of other research firms also recently weighed in on THC. Barclays upped their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Guggenheim upped their target price on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. Jefferies Financial Group lifted their price target on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. JPMorgan Chase & Co. increased their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, UBS Group lifted their target price on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Trading Down 0.4%

NYSE:THC opened at $238.68 on Friday. The stock’s 50-day moving average is $206.02 and its two-hundred day moving average is $199.95. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market cap of $20.76 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 1.18 and a beta of 1.44. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $240.83.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.81% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently modified their holdings of THC. WCM Investment Management LLC grew its holdings in Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares during the last quarter. AlphaQuest LLC lifted its position in shares of Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after purchasing an additional 4,202 shares in the last quarter. Winnow Wealth LLC acquired a new stake in shares of Tenet Healthcare in the third quarter valued at approximately $1,129,000. Cerity Partners LLC raised its position in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after purchasing an additional 11,395 shares during the last quarter. Finally, Savant Capital LLC boosted its position in Tenet Healthcare by 27.5% in the 3rd quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after buying an additional 3,647 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Zacks raised FY2026 EPS to $16.76 (from $15.41) — a meaningful upward revision to 2026 company-level earnings expectations. MarketBeat THC coverage
• Positive Sentiment: Q1 2026 EPS was increased to $4.14 (from $3.73), signalling stronger near-term operating performance. MarketBeat THC coverage
• Positive Sentiment: Q2 2026 EPS was raised to $4.10 (from $3.68), another near-term upward tweak. MarketBeat THC coverage
• Positive Sentiment: Zacks also lifted several quarterly 2026–2027 estimates (Q3 2026 to $4.08, Q4 2026 to $4.44, Q1 2027 to $4.31, and Q2 2027 slightly to $4.75), indicating expected stronger cadence through 2026 and into early 2027. MarketBeat THC coverage
• Positive Sentiment: Zacks published an FY2028 estimate of $17.80 EPS (new forward-year view), which supports a bullish longer-term earnings trajectory if achieved. MarketBeat THC coverage
• Negative Sentiment: Zacks cut FY2027 EPS to $16.35 from $17.98 — a notable decrease to next‑year full‑year expectations that can temper forward valuation. MarketBeat THC coverage
• Negative Sentiment: Q4 2027 was sharply lowered (to $3.28 from $4.82), representing the largest single-quarter downward revision and a driver of weaker medium-term visibility. MarketBeat THC coverage
• Negative Sentiment: Q3 2027 was reduced to $4.01 (from $4.38), another cut to later‑period quarterly expectations. MarketBeat THC coverage

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.